Key Takeaways
- A new draft guidance describes the FDA's considerations when deciding whether a confirmatory trial is underway prior to accelerated approval.
The US Food and Drug Administration will consider study enrollment, accrual rates and clinical site activations, among other factors, in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?